ミニブタの皮質電気生理学記録のための軟皮質電気皮質検査アレイの硬膜下移植

Executive Industry Relevance

Subdural implantation of soft electrocorticography (ECoG) arrays in minipigs enables high-fidelity cortical electrophysiology recordings in a translationally relevant large-animal model. This capability supports early-stage target validation and mechanistic de-risking for CNS drug discovery, particularly in auditory and neuroprosthetic research. The approach enhances predictive confidence for portfolio decisions by bridging preclinical and translational neuroscience workflows.

Strategic Applications in Biopharma R&D

Early Discovery & Target Validation

• Enables direct interrogation of cortical circuit function in a large-animal model.
• Supports mechanistic de-risking by capturing stimulus-evoked neuronal activity.
• Facilitates functional target validation for auditory and CNS pathways.
• Provides quantitative electrophysiological endpoints for hypothesis testing.

Screening & Assay Development

• Establishes a validated platform for longitudinal cortical activity monitoring.
• Delivers reproducible, quantitative readouts for compound or device evaluation.
• Supports assay standardization across preclinical studies in translational models.
• Enables screening of neuromodulatory interventions with high temporal resolution.

Translational & Preclinical Research

• Aligns preclinical electrophysiology with human-relevant cortical mapping.
• Facilitates continuity from discovery through preclinical validation in large animals.
• Supports risk-adjusted advancement of CNS assets with translational biomarkers.
• Provides a platform for evaluating neuroprosthetic and auditory therapeutics.

Pipeline & Workflow Integration

This method integrates into the discovery-to-preclinical continuum by enabling direct cortical recordings in a model with human-like neuroanatomy, supporting both mechanistic studies and translational biomarker development.

• Discovery Biology: Supports hypothesis testing and pathway clarification via stimulus-evoked cortical recordings.
• Screening: Provides assay-ready, reproducible electrophysiological outputs for compound or device testing.
• Analytics: Enables quantitative comparison of baseline and stimulus-evoked neuronal activity.
• Translational Research: Bridges preclinical findings to human cortical function through large-animal modeling.
• Enterprise Reuse: Offers a reusable platform for diverse CNS and auditory research programs.

Operational & Enterprise Impact

• Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in CNS target validation.
• Operational Value: Standardizes cortical recording procedures for reproducibility and scalability.
• Strategic Value: Informs go/no-go decisions and reduces late-stage biological risk in neurotherapeutic portfolios.
• Portfolio Impact: Enables risk-adjusted prioritization of CNS and auditory assets based on translational data.

Implementation Considerations

• Requires expertise in neurosurgical implantation and electrophysiology in large animals.
• Demands specialized instrumentation for wireless cortical signal acquisition and analysis.
• Necessitates cross-team standardization of surgical and recording protocols.
• Adaptation may be needed for different cortical regions or disease models.
• Long-term stability and signal quality depend on precise surgical technique and post-operative care.

Biopharma FAQs